Global Recombinant Vaccine Market Analysis 2016-2020 and Forecast 2021-2026
SNAPSHOT
The global Recombinant Vaccine market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Recombinant Vaccine by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
The global Recombinant Vaccine market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Recombinant Vaccine by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
- Subunit Recombinant Vaccines
- Attenuated Recombinant Vaccines
- Vector Recombinant Vaccines
- Merck & Co., Inc.
- Green Cross Corporation
- Pfizer, Inc.
- Sanofi S A.
- Protein Science Corporation
- GlaxoSmithKline Plc
- Novartis AG
- Bharat Biotech
- Human
- Animal
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
- Asia-Pacific (China, India, Japan, Southeast Asia etc.)
- South America (Brazil, Argentina etc.)
- Middle East & Africa (Saudi Arabia, South Africa etc.)
1 INDUSTRY OVERVIEW
1.1 Recombinant Vaccine Industry
Figure Recombinant Vaccine Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Recombinant Vaccine
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Recombinant Vaccine
1.2.2 Downstream
Table Application Segment of Recombinant Vaccine
Table Global Recombinant Vaccine Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 RECOMBINANT VACCINE MARKET BY TYPE
3.1 By Type
3.1.1 Subunit Recombinant Vaccines
Table Major Company List of Subunit Recombinant Vaccines
3.1.2 Attenuated Recombinant Vaccines
Table Major Company List of Attenuated Recombinant Vaccines
3.1.3 Vector Recombinant Vaccines
Table Major Company List of Vector Recombinant Vaccines
3.2 Market Size
Table Global Recombinant Vaccine Market 2016-2020, by Type, in USD Million
Figure Global Recombinant Vaccine Market Growth 2016-2020, by Type, in USD Million
Table Global Recombinant Vaccine Market 2016-2020, by Type, in Volume
Figure Global Recombinant Vaccine Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Recombinant Vaccine Market Forecast 2021-2026, by Type, in USD Million
Table Global Recombinant Vaccine Market Forecast 2021-2026, by Type, in Volume
4 MAJOR COMPANIES LIST
4.1 Merck & Co., Inc. (Company Profile, Sales Data etc.)
4.1.1 Merck & Co., Inc. Profile
Table Merck & Co., Inc. Overview List
4.1.2 Merck & Co., Inc. Products & Services
4.1.3 Merck & Co., Inc. Business Operation Conditions
Table Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Green Cross Corporation (Company Profile, Sales Data etc.)
4.2.1 Green Cross Corporation Profile
Table Green Cross Corporation Overview List
4.2.2 Green Cross Corporation Products & Services
4.2.3 Green Cross Corporation Business Operation Conditions
Table Business Operation of Green Cross Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Pfizer, Inc. (Company Profile, Sales Data etc.)
4.3.1 Pfizer, Inc. Profile
Table Pfizer, Inc. Overview List
4.3.2 Pfizer, Inc. Products & Services
4.3.3 Pfizer, Inc. Business Operation Conditions
Table Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Sanofi S A. (Company Profile, Sales Data etc.)
4.4.1 Sanofi S A. Profile
Table Sanofi S A. Overview List
4.4.2 Sanofi S A. Products & Services
4.4.3 Sanofi S A. Business Operation Conditions
Table Business Operation of Sanofi S A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Protein Science Corporation (Company Profile, Sales Data etc.)
4.5.1 Protein Science Corporation Profile
Table Protein Science Corporation Overview List
4.5.2 Protein Science Corporation Products & Services
4.5.3 Protein Science Corporation Business Operation Conditions
Table Business Operation of Protein Science Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
4.6.1 GlaxoSmithKline Plc Profile
Table GlaxoSmithKline Plc Overview List
4.6.2 GlaxoSmithKline Plc Products & Services
4.6.3 GlaxoSmithKline Plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Novartis AG (Company Profile, Sales Data etc.)
4.7.1 Novartis AG Profile
Table Novartis AG Overview List
4.7.2 Novartis AG Products & Services
4.7.3 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Bharat Biotech (Company Profile, Sales Data etc.)
4.8.1 Bharat Biotech Profile
Table Bharat Biotech Overview List
4.8.2 Bharat Biotech Products & Services
4.8.3 Bharat Biotech Business Operation Conditions
Table Business Operation of Bharat Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 MARKET COMPETITION
5.1 Company Competition
Table Global Recombinant Vaccine Sales Revenue 2016-2020, by Company, in USD Million
Table Global Recombinant Vaccine Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Recombinant Vaccine Sales Revenue Share in 2020, by Company, in USD Million
Table Global Recombinant Vaccine Sales Volume 2016-2020, by Company, in Volume
Table Global Recombinant Vaccine Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Recombinant Vaccine Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Recombinant Vaccine Market Concentration, in 2020
Figure Europe Recombinant Vaccine Market Market Concentration, in 2020
Figure Asia-Pacific Recombinant Vaccine MMarket Concentration, in 2020
Figure South America Recombinant Vaccine Market Concentration, in 2020
Figure Middle East & Africa Recombinant Vaccine Market Concentration, in 2020
6 DEMAND BY END MARKET
6.1 Demand Situation
6.1.1 Demand in Human
Figure Recombinant Vaccine Demand in Human, 2016-2020, in USD Million
Figure Recombinant Vaccine Demand in Human, 2016-2020, in Volume
6.1.2 Demand in Animal
Figure Recombinant Vaccine Demand in Animal, 2016-2020, in USD Million
Figure Recombinant Vaccine Demand in Animal, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Recombinant Vaccine Demand Forecast 2021-2026, by Application, in USD Million
Figure Recombinant Vaccine Market Growth 2021-2026, by Application, in USD Million
Figure Recombinant Vaccine Market Share in 2026, by Application, in USD Million
Table Recombinant Vaccine Demand Forecast 2021-2026, by Application, in Volume
Table Recombinant Vaccine Market Growth 2021-2026, by Application, in Volume
Table Recombinant Vaccine Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 REGION OPERATION
7.1 Regional Production
Table Recombinant Vaccine Production 2016-2020, by Region, in USD Million
Table Recombinant Vaccine Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Recombinant Vaccine Market 2016-2020, by Region, in USD Million
Table Global Recombinant Vaccine Market Share 2016-2020, by Region, in USD Million
Table Global Recombinant Vaccine Market 2016-2020, by Region, in Volume
Table Global Recombinant Vaccine Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
Figure North America Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
Table North America Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
Figure Europe Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
Table Europe Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
Figure South America Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
Table South America Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Recombinant Vaccine Market Forecast 2021-2026, by Region, in USD Million
Table Recombinant Vaccine Market Forecast 2021-2026, by Region, in Volume
8 MARKETING & PRICE
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 RESEARCH CONCLUSION
1.1 Recombinant Vaccine Industry
Figure Recombinant Vaccine Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Recombinant Vaccine
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Recombinant Vaccine
1.2.2 Downstream
Table Application Segment of Recombinant Vaccine
Table Global Recombinant Vaccine Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 RECOMBINANT VACCINE MARKET BY TYPE
3.1 By Type
3.1.1 Subunit Recombinant Vaccines
Table Major Company List of Subunit Recombinant Vaccines
3.1.2 Attenuated Recombinant Vaccines
Table Major Company List of Attenuated Recombinant Vaccines
3.1.3 Vector Recombinant Vaccines
Table Major Company List of Vector Recombinant Vaccines
3.2 Market Size
Table Global Recombinant Vaccine Market 2016-2020, by Type, in USD Million
Figure Global Recombinant Vaccine Market Growth 2016-2020, by Type, in USD Million
Table Global Recombinant Vaccine Market 2016-2020, by Type, in Volume
Figure Global Recombinant Vaccine Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Recombinant Vaccine Market Forecast 2021-2026, by Type, in USD Million
Table Global Recombinant Vaccine Market Forecast 2021-2026, by Type, in Volume
4 MAJOR COMPANIES LIST
4.1 Merck & Co., Inc. (Company Profile, Sales Data etc.)
4.1.1 Merck & Co., Inc. Profile
Table Merck & Co., Inc. Overview List
4.1.2 Merck & Co., Inc. Products & Services
4.1.3 Merck & Co., Inc. Business Operation Conditions
Table Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Green Cross Corporation (Company Profile, Sales Data etc.)
4.2.1 Green Cross Corporation Profile
Table Green Cross Corporation Overview List
4.2.2 Green Cross Corporation Products & Services
4.2.3 Green Cross Corporation Business Operation Conditions
Table Business Operation of Green Cross Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Pfizer, Inc. (Company Profile, Sales Data etc.)
4.3.1 Pfizer, Inc. Profile
Table Pfizer, Inc. Overview List
4.3.2 Pfizer, Inc. Products & Services
4.3.3 Pfizer, Inc. Business Operation Conditions
Table Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Sanofi S A. (Company Profile, Sales Data etc.)
4.4.1 Sanofi S A. Profile
Table Sanofi S A. Overview List
4.4.2 Sanofi S A. Products & Services
4.4.3 Sanofi S A. Business Operation Conditions
Table Business Operation of Sanofi S A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Protein Science Corporation (Company Profile, Sales Data etc.)
4.5.1 Protein Science Corporation Profile
Table Protein Science Corporation Overview List
4.5.2 Protein Science Corporation Products & Services
4.5.3 Protein Science Corporation Business Operation Conditions
Table Business Operation of Protein Science Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
4.6.1 GlaxoSmithKline Plc Profile
Table GlaxoSmithKline Plc Overview List
4.6.2 GlaxoSmithKline Plc Products & Services
4.6.3 GlaxoSmithKline Plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Novartis AG (Company Profile, Sales Data etc.)
4.7.1 Novartis AG Profile
Table Novartis AG Overview List
4.7.2 Novartis AG Products & Services
4.7.3 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Bharat Biotech (Company Profile, Sales Data etc.)
4.8.1 Bharat Biotech Profile
Table Bharat Biotech Overview List
4.8.2 Bharat Biotech Products & Services
4.8.3 Bharat Biotech Business Operation Conditions
Table Business Operation of Bharat Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 MARKET COMPETITION
5.1 Company Competition
Table Global Recombinant Vaccine Sales Revenue 2016-2020, by Company, in USD Million
Table Global Recombinant Vaccine Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Recombinant Vaccine Sales Revenue Share in 2020, by Company, in USD Million
Table Global Recombinant Vaccine Sales Volume 2016-2020, by Company, in Volume
Table Global Recombinant Vaccine Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Recombinant Vaccine Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Recombinant Vaccine Market Concentration, in 2020
Figure Europe Recombinant Vaccine Market Market Concentration, in 2020
Figure Asia-Pacific Recombinant Vaccine MMarket Concentration, in 2020
Figure South America Recombinant Vaccine Market Concentration, in 2020
Figure Middle East & Africa Recombinant Vaccine Market Concentration, in 2020
6 DEMAND BY END MARKET
6.1 Demand Situation
6.1.1 Demand in Human
Figure Recombinant Vaccine Demand in Human, 2016-2020, in USD Million
Figure Recombinant Vaccine Demand in Human, 2016-2020, in Volume
6.1.2 Demand in Animal
Figure Recombinant Vaccine Demand in Animal, 2016-2020, in USD Million
Figure Recombinant Vaccine Demand in Animal, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Recombinant Vaccine Demand Forecast 2021-2026, by Application, in USD Million
Figure Recombinant Vaccine Market Growth 2021-2026, by Application, in USD Million
Figure Recombinant Vaccine Market Share in 2026, by Application, in USD Million
Table Recombinant Vaccine Demand Forecast 2021-2026, by Application, in Volume
Table Recombinant Vaccine Market Growth 2021-2026, by Application, in Volume
Table Recombinant Vaccine Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 REGION OPERATION
7.1 Regional Production
Table Recombinant Vaccine Production 2016-2020, by Region, in USD Million
Table Recombinant Vaccine Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Recombinant Vaccine Market 2016-2020, by Region, in USD Million
Table Global Recombinant Vaccine Market Share 2016-2020, by Region, in USD Million
Table Global Recombinant Vaccine Market 2016-2020, by Region, in Volume
Table Global Recombinant Vaccine Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
Figure North America Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
Table North America Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
Figure Europe Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
Table Europe Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
Figure South America Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
Table South America Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Recombinant Vaccine Market Forecast 2021-2026, by Region, in USD Million
Table Recombinant Vaccine Market Forecast 2021-2026, by Region, in Volume
8 MARKETING & PRICE
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 RESEARCH CONCLUSION
LIST OF TABLES
1. Table Upstream Segment of Recombinant Vaccine
2. Table Application Segment of Recombinant Vaccine
3. Table Global Recombinant Vaccine Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Attenuated Recombinant Vaccines
5. Table Major Company List of Vector Recombinant Vaccines
6. Table Global Recombinant Vaccine Market 2016-2020, by Type, in USD Million
7. Table Global Recombinant Vaccine Market 2016-2020, by Type, in Volume
8. Table Global Recombinant Vaccine Market Forecast 2021-2026, by Type, in USD Million
9. Table Global Recombinant Vaccine Market Forecast 2021-2026, by Type, in Volume
10. Table Merck & Co., Inc. Overview List
11. Table Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
12. Table Green Cross Corporation Overview List
13. Table Business Operation of Green Cross Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Pfizer, Inc. Overview List
15. Table Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Sanofi S A. Overview List
17. Table Business Operation of Sanofi S A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Protein Science Corporation Overview List
19. Table Business Operation of Protein Science Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table GlaxoSmithKline Plc Overview List
21. Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Novartis AG Overview List
23. Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Bharat Biotech Overview List
25. Table Business Operation of Bharat Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Global Recombinant Vaccine Sales Revenue 2016-2020, by Company, in USD Million
27. Table Global Recombinant Vaccine Sales Revenue Share 2016-2020, by Company, in USD Million
28. Table Global Recombinant Vaccine Sales Volume 2016-2020, by Company, in Volume
29. Table Global Recombinant Vaccine Sales Volume Share 2016-2020, by Company, in Volume
30. Table Regional Demand Comparison List
31. Table Major Application in Different Regions
32. Table Recombinant Vaccine Demand Forecast 2021-2026, by Application, in USD Million
33. Table Recombinant Vaccine Demand Forecast 2021-2026, by Application, in Volume
34. Table Recombinant Vaccine Market Growth 2021-2026, by Application, in Volume
35. Table Recombinant Vaccine Market Share in 2026, by Application, in Volume
36. Table Recombinant Vaccine Production 2016-2020, by Region, in USD Million
37. Table Recombinant Vaccine Production 2016-2020, by Region, in Volume
38. Table Global Recombinant Vaccine Market 2016-2020, by Region, in USD Million
39. Table Global Recombinant Vaccine Market Share 2016-2020, by Region, in USD Million
40. Table Global Recombinant Vaccine Market 2016-2020, by Region, in Volume
41. Table Global Recombinant Vaccine Market Share 2016-2020, by Region, in Volume
42. Table North America Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
43. Table North America Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
44. Table Europe Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
45. Table Europe Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
46. Table Asia-Pacific Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
47. Table Asia-Pacific Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
48. Table South America Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
49. Table South America Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
50. Table Middle East & Africa Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
51. Table Middle East & Africa Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
52. Table Recombinant Vaccine Market Forecast 2021-2026, by Region, in USD Million
53. Table Recombinant Vaccine Market Forecast 2021-2026, by Region, in Volume
54. Table Price Factors List
1. Table Upstream Segment of Recombinant Vaccine
2. Table Application Segment of Recombinant Vaccine
3. Table Global Recombinant Vaccine Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Attenuated Recombinant Vaccines
5. Table Major Company List of Vector Recombinant Vaccines
6. Table Global Recombinant Vaccine Market 2016-2020, by Type, in USD Million
7. Table Global Recombinant Vaccine Market 2016-2020, by Type, in Volume
8. Table Global Recombinant Vaccine Market Forecast 2021-2026, by Type, in USD Million
9. Table Global Recombinant Vaccine Market Forecast 2021-2026, by Type, in Volume
10. Table Merck & Co., Inc. Overview List
11. Table Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
12. Table Green Cross Corporation Overview List
13. Table Business Operation of Green Cross Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Pfizer, Inc. Overview List
15. Table Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Sanofi S A. Overview List
17. Table Business Operation of Sanofi S A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Protein Science Corporation Overview List
19. Table Business Operation of Protein Science Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table GlaxoSmithKline Plc Overview List
21. Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Novartis AG Overview List
23. Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Bharat Biotech Overview List
25. Table Business Operation of Bharat Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Global Recombinant Vaccine Sales Revenue 2016-2020, by Company, in USD Million
27. Table Global Recombinant Vaccine Sales Revenue Share 2016-2020, by Company, in USD Million
28. Table Global Recombinant Vaccine Sales Volume 2016-2020, by Company, in Volume
29. Table Global Recombinant Vaccine Sales Volume Share 2016-2020, by Company, in Volume
30. Table Regional Demand Comparison List
31. Table Major Application in Different Regions
32. Table Recombinant Vaccine Demand Forecast 2021-2026, by Application, in USD Million
33. Table Recombinant Vaccine Demand Forecast 2021-2026, by Application, in Volume
34. Table Recombinant Vaccine Market Growth 2021-2026, by Application, in Volume
35. Table Recombinant Vaccine Market Share in 2026, by Application, in Volume
36. Table Recombinant Vaccine Production 2016-2020, by Region, in USD Million
37. Table Recombinant Vaccine Production 2016-2020, by Region, in Volume
38. Table Global Recombinant Vaccine Market 2016-2020, by Region, in USD Million
39. Table Global Recombinant Vaccine Market Share 2016-2020, by Region, in USD Million
40. Table Global Recombinant Vaccine Market 2016-2020, by Region, in Volume
41. Table Global Recombinant Vaccine Market Share 2016-2020, by Region, in Volume
42. Table North America Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
43. Table North America Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
44. Table Europe Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
45. Table Europe Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
46. Table Asia-Pacific Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
47. Table Asia-Pacific Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
48. Table South America Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
49. Table South America Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
50. Table Middle East & Africa Recombinant Vaccine Market Size 2016-2020, by Country, in USD Million
51. Table Middle East & Africa Recombinant Vaccine Market Size 2016-2020, by Country, in Volume
52. Table Recombinant Vaccine Market Forecast 2021-2026, by Region, in USD Million
53. Table Recombinant Vaccine Market Forecast 2021-2026, by Region, in Volume
54. Table Price Factors List
LIST OF FIGURES
1. Figure Recombinant Vaccine Industry Chain Structure
2. Figure Global Recombinant Vaccine Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Recombinant Vaccine Market Growth 2016-2020, by Type, in Volume
4. Figure Global Recombinant Vaccine Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Recombinant Vaccine Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Recombinant Vaccine Market Concentration, in 2020
7. Figure Europe Recombinant Vaccine Market Market Concentration, in 2020
8. Figure Asia-Pacific Recombinant Vaccine MMarket Concentration, in 2020
9. Figure South America Recombinant Vaccine Market Concentration, in 2020
10. Figure Middle East & Africa Recombinant Vaccine Market Concentration, in 2020
11. Figure Recombinant Vaccine Demand in Human, 2016-2020, in USD Million
12. Figure Recombinant Vaccine Demand in Human, 2016-2020, in Volume
13. Figure Recombinant Vaccine Demand in Animal, 2016-2020, in USD Million
14. Figure Recombinant Vaccine Demand in Animal, 2016-2020, in Volume
15. Figure Recombinant Vaccine Market Growth 2021-2026, by Application, in USD Million
16. Figure Recombinant Vaccine Market Share in 2026, by Application, in USD Million
17. Figure North America Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
18. Figure North America Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
19. Figure Europe Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
20. Figure Europe Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
21. Figure Asia-Pacific Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
22. Figure Asia-Pacific Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
23. Figure South America Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
24. Figure South America Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
25. Figure Middle East & Africa Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
26. Figure Middle East & Africa Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
27. Figure Marketing Channels Overview
1. Figure Recombinant Vaccine Industry Chain Structure
2. Figure Global Recombinant Vaccine Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Recombinant Vaccine Market Growth 2016-2020, by Type, in Volume
4. Figure Global Recombinant Vaccine Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Recombinant Vaccine Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Recombinant Vaccine Market Concentration, in 2020
7. Figure Europe Recombinant Vaccine Market Market Concentration, in 2020
8. Figure Asia-Pacific Recombinant Vaccine MMarket Concentration, in 2020
9. Figure South America Recombinant Vaccine Market Concentration, in 2020
10. Figure Middle East & Africa Recombinant Vaccine Market Concentration, in 2020
11. Figure Recombinant Vaccine Demand in Human, 2016-2020, in USD Million
12. Figure Recombinant Vaccine Demand in Human, 2016-2020, in Volume
13. Figure Recombinant Vaccine Demand in Animal, 2016-2020, in USD Million
14. Figure Recombinant Vaccine Demand in Animal, 2016-2020, in Volume
15. Figure Recombinant Vaccine Market Growth 2021-2026, by Application, in USD Million
16. Figure Recombinant Vaccine Market Share in 2026, by Application, in USD Million
17. Figure North America Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
18. Figure North America Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
19. Figure Europe Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
20. Figure Europe Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
21. Figure Asia-Pacific Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
22. Figure Asia-Pacific Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
23. Figure South America Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
24. Figure South America Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
25. Figure Middle East & Africa Recombinant Vaccine Market Size and Growth 2016-2020, in USD Million
26. Figure Middle East & Africa Recombinant Vaccine Market Size and Growth 2016-2020, in Volume
27. Figure Marketing Channels Overview
